Bavarian Nordic A/S (BVNRY)
11.16
-0.06
(-0.58%)
USD |
OTCM |
Sep 24, 16:00
Bavarian Nordic Cash from Operations (TTM) : 221.90M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 221.90M |
| March 31, 2026 | 350.04M |
| December 31, 2025 | 413.17M |
| September 30, 2025 | 468.58M |
| June 30, 2025 | 258.47M |
| March 31, 2025 | 166.34M |
| December 31, 2024 | 284.31M |
| September 30, 2024 | 227.81M |
| June 30, 2024 | 282.57M |
| March 31, 2024 | 255.63M |
| December 31, 2023 | 161.32M |
| September 30, 2023 | 108.45M |
| June 30, 2023 | 81.64M |
| March 31, 2023 | -3.681M |
| December 31, 2022 | 30.86M |
| September 30, 2022 | -16.88M |
| June 30, 2022 | -13.58M |
| March 31, 2022 | -34.09M |
| December 31, 2021 | -57.04M |
| September 30, 2021 | -101.10M |
| June 30, 2021 | -73.02M |
| March 31, 2021 | 4.208M |
| December 31, 2020 | 87.27M |
| September 30, 2020 | 147.74M |
| June 30, 2020 | 92.10M |
| Date | Value |
|---|---|
| March 31, 2020 | 33.12M |
| December 31, 2019 | -41.36M |
| September 30, 2019 | -38.94M |
| June 30, 2019 | -29.36M |
| March 31, 2019 | -22.29M |
| December 31, 2018 | -45.67M |
| September 30, 2018 | -72.21M |
| June 30, 2018 | -86.02M |
| March 31, 2018 | -25.34M |
| December 31, 2017 | 32.76M |
| September 30, 2017 | 153.39M |
| June 30, 2017 | 129.61M |
| March 31, 2017 | 73.57M |
| December 31, 2016 | 39.76M |
| September 30, 2016 | -80.97M |
| June 30, 2016 | -51.79M |
| March 31, 2016 | -84.66M |
| December 31, 2015 | 15.66M |
| September 30, 2015 | 139.14M |
| June 30, 2015 | 137.22M |
| March 31, 2015 | 165.38M |
| December 31, 2014 | 60.28M |
| September 30, 2014 | -12.08M |
| June 30, 2014 | -19.47M |
| March 31, 2014 | 31.52M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Evaxion AS | -- |
| Genmab A/S | 891.90M |
| Ascendis Pharma A/S | 405.71M |
| Zealand Pharma A/S | -241.46M |
| Agenus, Inc. | -98.50M |